Compound 522
Identifiers
- Canonical SMILES:
COCCNC(=O)[C@@H]1[C@@H](CO)[C@@H]2Cn3c(cccc3=O)[C@H]1N2c1nc(c(s1)-c1ccccc1)-c1ccc(Cl)cc1
- InChi:
InChI=1S/C30H29ClN4O4S/c1-39-15-14-32-29(38)25-21(17-36)23-16-34-22(8-5-9-24(34)37)27(25)35(23)30-33-26(18-10-12-20(31)13-11-18)28(40-30)19-6-3-2-4-7-19/h2-13,21,23,25,27,36H,14-17H2,1H3,(H,32,38)/t21-,23-,25+,27+/m0/s1
- InChiKey:
TUWXDFQYVJARAO-JZEPBHRJSA-N
External links
44574949 |
CHEMBL502454 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.37 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 576.16 g/mol | |||
HBA | 8 | |||
HBD | 2 | |||
HBA + HBD | 10 | |||
AlogP | 3.69 | |||
TPSA | 95.00 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4830 | Alpelisib | DB12015 | |
0.4571 | Lintitript | DB04867 | |
0.4533 | Vedroprevir | DB12037 | |
0.4404 | Faldaprevir | DB11808 | |
0.4320 | GS-9256 | DB12876 | |
0.4271 | Ciluprevir | DB05868 | |
0.4242 | Fenebrutinib | DB14785 | |
0.4173 | Vintafolide | DB05168 | |
0.4135 | LFF-571 | DB13013 | |
0.4122 | Ziritaxestat | DB15403 | |
0.4087 | Avatrombopag | DB11995 | |
0.4049 | N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide | DB06836 | |
0.4000 | (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE | DB07406 | |
0.4000 | Samatasvir | DB12660 | |
0.3996 | GE-2270A | DB02975 |